Table 3. The estimated cost of the different regimens.
Treatment | Drugs (US$) | Tests
(US$) |
Consultation
fees (US$) |
Total treatment cost
(US$) |
|
---|---|---|---|---|---|
Total | Average
per week |
||||
Genotype 2/3: 24-week treatment regimen | |||||
IFN α-2a + ribavirin | 619.17 – 655.17 | 25.79 - 27.30 | 498.18 | 13.95 | 1,155.29 – 1,167.31 |
IFN α-2b + ribavirin | 607.75 – 619.77 | 25.32 - 25.82 | 498.18 | 13.95 | 1,119.88 – 1,131.90 |
Peg-IFN α-2a +
ribavirin |
1,644.14 – 2,617.89 | 68.50 - 109.07 | 498.18 | 13.95 | 2,156.27 – 3,130.02 |
Peg-IFN α-2b +
ribavirin |
1,680.07 – 1,967.78 | 70.00 - 81.99 | 498.18 | 13.95 | 2,192.20 – 2,470.91 |
Genotype 1/4/6: 48-week treatment regimen | |||||
IFN α-2a + ribavirin | 1,325.52 – 1,333.78 | 27.61 - 27.79 | 613.24 | 24.41 | 1,953.84 – 1,961.90 |
IFN α-2b + ribavirin | 1,254.71 – 1,262.97 | 26.14 - 26.31 | 613.24 | 24.41 | 1,882.83 – 1,892.09 |
Peg-IFN α-2a +
ribavirin |
3,327.48 – 5,259.20 | 69.32 - 109.57 | 613.24 | 24.41 | 3,955.60 – 5,887.32 |
Peg-IFN α-2b +
ribavirin |
3,375.89 – 3,950.73 | 70.33 - 82.30 | 613.24 | 24.41 | 4,003.43 – 4,578.85 |
The range in the costs for a given regimen is due to the variation in the costs of the different brands of the drugs and the different dosages (minimum and maximum values are shown in Table 4). Costs are in 2017 prices.